Non-Neutropenic Sepsis in Cancer Patients: The Luminal Obstruction Syndrome
- 1 Department of Oncoradiology, Petz Aladár Hospital, Gyor, Hungary
- 2 Department of Oncoradiology, Petz Aladár Hospital, Gyor, Hungary
- 3 Department of Oncoradiology, Petz Aladár Hospital, Gyor, Hungary
Abstract
Background: Neutropenic sepsis is a frequent complication of cytotoxic chemotherapy delivered for cancer patients . Its management is well determined by clinical guidelines. Non-neutropenic sepsis is another potential complication in cancer patients. Its management is less established in the medical literature. Materials and Methods: Three cases are presented to illustrate favourable evolution of non-neutropenic biliary-, uro - and bronchogenic - sepsis in cancer patients with poor prognosis. Results: All three patients had a survival over six months after the management of the septic complication. Two of them received subsequent systemic anticancer treatment. Conclusions: Survival benefit offered by the management of cancer - related non-neutropenic sepsis may be comparable to the benefit obtained by systemic anticancer treatments. Cost - effectiveness of sepsis management may be better than that of anticancer treatments.
- Sood, A., Abdollah, F., Sammon, J.D., Arora, N., Weeks, M., Peabody, J.O., Menon, M. and Trinh, Q.D. (2017) Postoperative Sepsis Prediction in Patients Undergoing Major Cancer Surgery. Journal of Surgical Research, 209, 60-69. https://doi.org/10.1016/j.jss.2016.09.059
- Kochanek, M., Schalk, E., von Bergwelt-Baildon, M., Beutel, G., Buchheidt, D., Hentrich, M., Henze, L., Kiehl, M., Liebregts, T., von Lilienfeld-Toal, M., Classen, A., Mellinghoff, S., Penack, O., Piepel, C. and Boll, B. (2019) Management of Sepsis in Neutropenic Cancer Patients: 2018 Guidelines from the Infectious Diseases Working Party (AGIHO) and Intensive Care Working Party (iCHOP) of the German Society of Hematology and Medical Oncology (DGHO). Annals of Hematology, 98, 1051-1069. https://doi.org/10.1007/s00277-019-03622-0
- Raad, I. and Chaftari, A.M. (2014) Advances in Prevention and Management of Central Line-Associated Bloodstream Infections in Patients with Cancer. Clinical Infectious Diseases, 59, 340-343. https://doi.org/10.1093/cid/ciu670
- Wilson, T., Cooksley, T., Churchill, S., Radford, J. and Dark, P. (2018) Retrospective Analysis of Cancer Patients Admitted to a Tertiary Centre with Suspected Neutropenic Sepsis: Are C-Reactive Protein and Neutrophil Count Useful Prognostic Biomarkers? Journal of the Intensive Care Society, 19, 132-137. https://doi.org/10.1177/1751143717741248
- Ferrer, R., Martin-Loeches, I., Phillips, G., Osborn, T.M., Townsend, S., Dellinger, R.P., Artigas, A., Schorr, C. and Levy, M.M. (2014) Empiric Antibiotic Treatment Reduces Mortality in Severe Sepsis and Septic Shock from the First Hour: Results from a Guideline-Based Performance Improvement Program. Critical Care Medicine, 42, 1749-1755. https://doi.org/10.1097/CCM.0000000000000330
- de Montmollin, E., Tandjaoui-Lambiotte, Y., Legrand, M., Lambert, J., Mokart, D., Kouatchet, A., Lemiale, V., Pène, F., Bruneel, F., Vincent, F., Mayaux, J., Chevret, S. and Azoulay, E. (2013) Outcomes in Critically Ill Cancer Patients with Septic Shock of Pulmonary Origin. Shock, 39, 250-254. https://doi.org/10.1097/SHK.0b013e3182866d32
- Gudiol, C., Aguado, J.M. and Carratalà, J. (2016) Bloodstream Infections in Patients with Solid Tumors. Virulence, 7, 298-308. https://doi.org/10.1080/21505594.2016.1141161
- Sebbagh, S., Roux, J., Dreyer, C., Neuzillet, C., de Gramont, A., Orbegoso, C., Hentic, O., Hammel, P., de Gramont, A., Raymond, E., André, T., Chibaudel, B. and Faivre, S. (2016) Efficacy of a Sequential Treatment Strategy with GEMOX-Based Followed by FOLFIRI-Based Chemotherapy in Advanced Biliary Tract Cancers. Acta Oncologica, 55, 1168-1174. https://doi.org/10.1080/0284186X.2016.1191670